These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2865763)

  • 21. Differential regulation of the brain and gut immunoreactive dynorphin by the serotonin system.
    Majeed NH; Lasoń W; Przewłocka B; Przewłocki R
    Life Sci; 1985 Jul; 37(4):339-43. PubMed ID: 2861553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lesions of the hypothalamic arcuate nucleus modify discrete brain and pituitary pools of dynorphin in addition to beta-endorphin in the rat.
    Millan MH; Millan MJ; Przewłocki R
    Neurosci Lett; 1984 Jul; 48(2):149-54. PubMed ID: 6148723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of immunoreactive dynorphin A1-8 in discrete nuclei of the rat brain: comparison with dynorphin A.
    Zamir N; Palkovits M; Brownstein MJ
    Brain Res; 1984 Jul; 307(1-2):61-8. PubMed ID: 6147178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of dynorphin-(1-13) immunoreactivity in rat neurointermediate pituitaries are concomitantly altered with those of leucine enkephalin and vasopressin in response to various endocrine manipulations.
    Höllt V; Haarmann I; Seizinger BR; Herz A
    Neuroendocrinology; 1981 Dec; 33(6):333-9. PubMed ID: 6275285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary.
    Seizinger BR; Höllt V; Herz A
    Endocrinology; 1984 Aug; 115(2):662-71. PubMed ID: 6146512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary.
    Sivam SP; Smith DR; Takeuchi K; Hong JS
    Neuropeptides; 1987 Oct; 10(3):291-8. PubMed ID: 2891076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hypothalamic lesions on the content of dynorphin immunoreactivity in pituitary.
    Spampinato S; Candeletti S; Romualdi P; Russo A; Stanzani S; Ferri S
    Life Sci; 1983; 33 Suppl 1():503-6. PubMed ID: 6141497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody specific for a dynorphin precursor.
    Barrett RW; Goldstein A
    Neuropeptides; 1985 Apr; 6(2):113-20. PubMed ID: 2860615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of foot-shock stress upon brain, pituitary and spinal cord pools of immunoreactive dynorphin in rats.
    Millan MJ; Tsang YF; Prezewłocki R; Höllt V; Herz A
    Neurosci Lett; 1981 Jun; 24(1):75-9. PubMed ID: 6115344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat.
    Millan MJ; Millan MH; Reid LD; Herz A
    Brain Res; 1986 Aug; 381(1):29-42. PubMed ID: 2875765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the ventromedial hypothalamus in the regulation of adenohypophyseal immunoreactive dynorphin in the rat.
    Spampinato S; Stanzani S; Leanza G; Russo A; Ferri S
    Brain Res; 1988 Oct; 463(1):100-6. PubMed ID: 2904293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of dynorphin-like immunoreactivity from rat adenohypophysis in vitro during inhibition of anterior pituitary hormone secretion from individual cell types.
    Schwaninger M; Knepel W; Döhler KD; Sandow J
    Endocrinology; 1987 Jul; 121(1):167-74. PubMed ID: 2885174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadal steroids and anterior lobe dynorphin in the male rat.
    Fullerton MJ; Smith AI; Clements JA; Funder JW
    J Steroid Biochem; 1989 Feb; 32(2):303-8. PubMed ID: 2564056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of brain and pituitary pools of dynorphin as compared to vasopressin to acute stress in the rat.
    Millan MJ; Millan MH; Tsang YF; Herz A
    Life Sci; 1983; 33 Suppl 1():29-32. PubMed ID: 6141491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatographic system for the separation of dynorphin A (1-17) fragments and its application in enzymolysis studies with rat nerve terminal membranes.
    Seyfried CA; Tobler P
    J Chromatogr; 1990 Jul; 529(1):43-54. PubMed ID: 1976647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin-induced hypophagia is not potentiated by cancer anorexia.
    van Lammeren FM; Chance WT; Fischer JE
    Peptides; 1984; 5(1):97-101. PubMed ID: 6324152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain tryptophan and the neoplastic anorexia-cachexia syndrome.
    Krause R; James JH; Ziparo V; Fischer JE
    Cancer; 1979 Sep; 44(3):1003-8. PubMed ID: 289432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.